| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Basal insulin and cardiovascular and other outcomes in dysglycemia.
|
N Engl J Med
|
2012
|
10.09
|
|
2
|
Effect of ramipril on the incidence of diabetes.
|
N Engl J Med
|
2006
|
9.69
|
|
3
|
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
|
JAMA
|
2005
|
7.35
|
|
4
|
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.
|
N Engl J Med
|
2014
|
6.65
|
|
5
|
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
|
N Engl J Med
|
2012
|
6.16
|
|
6
|
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.
|
JAMA
|
2012
|
4.58
|
|
7
|
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.
|
Diabetes Care
|
2014
|
3.31
|
|
8
|
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
|
Am Heart J
|
2007
|
3.12
|
|
9
|
Specific barriers to the conduct of randomized trials.
|
Clin Trials
|
2008
|
2.68
|
|
10
|
Randomized clinical trials--removing unnecessary obstacles.
|
N Engl J Med
|
2013
|
2.43
|
|
11
|
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
|
Circulation
|
2003
|
1.98
|
|
12
|
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.
|
CMAJ
|
2012
|
1.86
|
|
13
|
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.
|
Am Heart J
|
2005
|
1.65
|
|
14
|
Cognitive impairment and risk of cardiovascular events and mortality.
|
Eur Heart J
|
2012
|
1.60
|
|
15
|
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
|
J Am Coll Cardiol
|
2009
|
1.54
|
|
16
|
The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.
|
Circulation
|
2010
|
1.51
|
|
17
|
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.
|
Anesthesiology
|
2014
|
1.47
|
|
18
|
Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.
|
Eur Heart J
|
2007
|
1.46
|
|
19
|
Obesity genes and risk of major depressive disorder in a multiethnic population: a cross-sectional study.
|
J Clin Psychiatry
|
2015
|
1.41
|
|
20
|
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
|
Diabetes Care
|
2002
|
1.40
|
|
21
|
Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
|
J Am Coll Cardiol
|
2004
|
1.28
|
|
22
|
Sensible guidelines for the conduct of large randomized trials.
|
Clin Trials
|
2008
|
1.07
|
|
23
|
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.
|
Eur Heart J
|
2013
|
1.01
|
|
24
|
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.
|
Am Heart J
|
2012
|
0.99
|
|
25
|
Lipid lowering for primary prevention.
|
Lancet
|
2009
|
0.98
|
|
26
|
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
|
Kidney Int
|
2004
|
0.98
|
|
27
|
The fluid study protocol: a randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients.
|
Perit Dial Int
|
2011
|
0.88
|
|
28
|
Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
|
Circulation
|
2004
|
0.88
|
|
29
|
Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients.
|
Eur J Cardiovasc Prev Rehabil
|
2003
|
0.87
|
|
30
|
Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).
|
Diabetes Care
|
2013
|
0.85
|
|
31
|
Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.
|
Diabetologia
|
2014
|
0.84
|
|
32
|
The mini-mental state examination, clinical factors, and motor vehicle crash risk.
|
J Am Geriatr Soc
|
2014
|
0.81
|
|
33
|
Effect of long-term therapy with ramipril in high-risk women.
|
J Am Coll Cardiol
|
2002
|
0.80
|
|
34
|
Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic study.
|
Diabetes Care
|
2013
|
0.79
|
|
35
|
Independent design and conduct of clinical trials.
|
Clin Trials
|
2006
|
0.78
|
|
36
|
Home and community occupational therapy for children and youth: a before and after study.
|
Can J Occup Ther
|
2005
|
0.77
|
|
37
|
Preventing stroke with ramipril--authors' reply.
|
BMJ
|
2003
|
0.75
|
|
38
|
Setting the record straight on TIDE: a lost opportunity for patients with diabetes.
|
Diabetologia
|
2013
|
0.75
|